VACCINOPROPHYLAXIS OF CHRONIC SOM AT IC DI SE A SE S E X AC E R B AT ION S I N GROUPS OF RISK


Cite item

Full Text

Abstract

Modern version of I.Mechnikov’s hypothesis on association of somatic diseases with infectious agents is presented. List of bacteria and viruses associated with various types of cardiomyopathies, atherosclerosis, gastritis, gastric and duodenal ulcerative disease, type 1 diabetes mellitus. Literature data showing that influenza vaccination reduces number of fatal myocardial infarctions and strokes during winter seasons as well as number of hospitalizations due to exacerbations of chronic cardiovascular and cerebrov- ascular diseases are summarized. Data on probability of coincidence of influenza vaccination and sudden death in elderly persons are reviewed.

About the authors

B. F Semenov

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

V. V Zverev

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

References

  1. Бекбосынова М.С., Лоладзе А.В., Пичугин Е.Ш. и др. Противовирусная иммунотерапия у больных с нарушением ритма сердца и иммунологическими признаками хронической вирусной инфекции. Иммунология. 2008, 29 (3): 156-164.
  2. Гендон Ю.З., Каира А.Н., Ельшина Г.А. и др. Массовая вакцинация детей против гриппа снижает заболеваемость рядом болезней пожилых людей во время гриппозной эпидемии. Журн. микробиол. 2004, 5: 62-67.
  3. Мечников И.И. Невосприимчивость в инфекционных болезнях. М., ГИМЛ, 1947.
  4. Медицинская микробиология, вирусология, иммунология. А.А. Воробьев (ред.). М., МИА, 2004.
  5. Сведения о числе заболеваний, зарегистрированных у больных, проживающих в районе обслуживания лечебного учреждения. Форма № 12. Минздравсоцразвития, 2008.
  6. Организация вакцинопрофилактики. Г.Г. Онищенко (ред.). М., ЦГЭ, 2007.
  7. Alvan O., Kocma Z.E., Ozdemir O. et al. Hepatitis C infection is associated with increased coronary artery atherosclerosis defined by modified reardon severity score system. Circ. J. 2008, 72 (12): 1960-1965.
  8. Altobelli E., Petrocelli R., Verrotti A. et al. Infections and risk of type 1 diabetes in childhood: population based case-control study. Eur. J. Epidemiol. 2003, 18 (5): 425-430.
  9. Andre F.E., Booy R., Bock H.L. et al. Vaccination greatly reduced disease, disability, death and inequity worldwide. Bull. WHO 2008, 86 (2):140-146.
  10. Chronic Disease Overview. http://www.cdc.gov/ nicdphp/overview.htm.
  11. Chapman N.M., Kim K.S. Persistent coxsackle virus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Curr. Top. Microbiol. Immunol. 2008, 323: 275-292.
  12. Davis M.M., Taubert K., Benin A.L. et al. Influenza vaccination as secondary prevention for cardiovascular disease. Circulation. 2006, 114: 1549-1553.
  13. ECDC influenza team. No link established be- tween deaths in elderly patients in Israel and influenza vaccination. Eurosurveillance. 2006, 11: doi 061026.
  14. Gurfinkel E.R., de la Fuente R.L., Mendiz O. et al. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions. Circulation. 2002, 108: 2143-2147.
  15. Hviid A., Melbye M. Measles-Mumps-Rubella vaccination and astma-lice disease in early childhood. Am.J. Epidemiol. 2008, 168:1277-1283.
  16. Hee-Sook Jun, Ji-Won Yoon. A new look at viruses in type 1 diabetes. Diabetes Metab. Res. Rev.2003, 19: 8-31.
  17. Kwok A., Lam T., Katelaris P. et al. Helicobacter pylori eradication therapy: indications, efficacy and safety. Expert. Opin. Drug. Saf. 2008, 7 (3): 271-281.
  18. Kol A., Santini M. Infectious agents and atherosclerosis: current perspectives and unsolved issues. Ital. Heart. J. 2004, 5 (5): 350-357.
  19. Kokia E.S., Silverman B.G., Green M. et al. Deaths following influenza vaccination - background mortality or causal connection? Vaccine. 2007, 25: 8557-8561.
  20. Kwong J.C., Stukel T.A., Lim J. et al. The effect of universal influenza immunization on mortality and health care use. Plos. Med. 2008, 5 (10): 1440-1452.
  21. Lamontagne F., Garant M-R., Carvalho J-C. et al. Pneumococcal vaccination and risk of myocardial infarction. CMA. J. 2008, 179: 773-777.
  22. Mamas M.A., Fraser D., Neyses L. Cardiovascular manifestations associated with influenza infection. Int. J. Card. 2008, 130: 304-309.
  23. Madjid M., Miller C.C., Zarubaev V.V. et al. Imfluenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34892 subjects. Europ. Heart. J. 2007, 28: 1205-1210.
  24. Maisch B., Ristic A.D., Portia I. et al. Human viral cardiomyopathy. Front. Biosci. 2003, 8: 39-67.
  25. Matsumori A. Role of hepatitis C virus in cardiomyopathies. Ernst. Schering. Res. Found. Workshop. 2006, 55: 99-120.
  26. Makova D., Peura D.A., Crowe S.E. Helicobacter pylori infection and related gastrointestinal diseases. J. Clin. Gastroenter. 2007, 44 (6): 548- 558.
  27. Milioti N., Bermudez-Fajardo A., Penichet M.L. Antigen-induced immunomodulation in pathogenesis of atherosclerosis. Clin. Dev. Immunol. 2008, 723: 35-39.
  28. McNamara D., El-Omar E. Helicobacter pylori infection and pathogenesis a gastric cancer: paradigm for host-bacterial interactions. Dig. Liver Dis. 2008, 40 (7): 504-509.
  29. Molinari N.M., Ortega-Sanchez J.R., Messonier M.L. The annual impact of seasonal influenza in the USA: Measuring disease burden and costs. Vaccine. 2007, 25: 5086-5096.
  30. Nichol K.L., Nordin J., Mullooly J. et al. Influenza vaccination and reduction in hospitalizations for cardiae disease and stroke among the elderly. N. Engl. J. Med. 2003, 348: 1322- 1332.
  31. Pankuweit S., Ruppert V., Eckhardt H. et al. Pathophysiology and aetiological diagnosis of inflammatory myocardial diseases with special focus on parvovirus B19. J. Vet. Med. Infect. Dis. 2005, 52: 344-347.
  32. Smeeth L., Thomas S.L., Yall A.J. et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N. Eng. J. Med. 2004, 351: 2611-2618.
  33. Sona Z., Brassard P., Brophy J.M. A metaanalysis of antibiotic use for the secondary prevention of cardiovascular diseases. Can. J. Cardiol. 2008, 24(5):391-395.
  34. Sano T. Influenza myocarditis and pericarditis. Nippon Rinsho. 2006, 64 (10): 1916-1920.
  35. Sweeth L., Thomas S.L., Hall A.J. et al. Risk of miocardial infraction and stroke ofter acute infection or vaccination. N. Engl. J. Med. 2004, 51: 2611-2618.
  36. van der Werf N., Kroese F.G., Rozing J. et al. Virus infections as a potential triggers of type 1 diabetes. Diabetes Metab. Res. Rev. 2007, 23 (3) 169-183.
  37. Vila-Corsoles A., Rodriguez T., de Diego C. et al. Effect of influenza vaccine status on winter mortality in Spanish community-dwelling elderly people during 2002-2005 influenza periods. Vaccine. 2007, 25:6699-6707.
  38. van der Sande M.A.B., van Asten L. et al. Sudden deaths following influenza vaccination: Can this be expected? Ibid. 2008, 26: 379-382.
  39. Voordouw A.C., Sturkenboom M.C., Dieleman J.P. et al. Annual revaccination against influenza and mortality risk in community-dwelling elderly persons. JAMA. 2004, 292: 2089-2095.
  40. Weck M.H., Brenner H. Assotiation of helicobacter infection with chronic atophic gastritis. Int. J. Cancer. 2008, 123 (4): 874-881.
  41. Watson C. Role of Chlamydia pneumoniae in atherosclerosis. Clin. Sci. (London). 2008, 114 (8): 509-531.
  42. Wang C.S., Wang S.T., Lai C.T. et al. Impact of influenza vaccination on major cause-specific mortality. Vaccine. 2007, 25: 1196-1201.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Semenov B.F., Zverev V.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies